達爾膚

+1.00 (+1.12%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

90.5014成交張數13.69本益比3.20股價淨值比11.05%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	16	13	22.5%	3.83	28.28	22.1%	17.1%	1.4	1.4
2026Q1	17	13	19.8%	4.47	29.96	19.5%	15.5%	0.3	0.3
2025Q4	16	14	14.8%	5.71	30.08	24.9%	21.0%	2.1	2.1
2025Q3	18	14	21.7%	3.89	32.14	27.0%	21.3%	-0.0	-0.0
2025Q2	18	14	22.4%	3.81	31.67	26.3%	20.1%	-0.0	-0.1
2025Q1	19	15	21.3%	3.76	33.74	30.6%	24.1%	1.4	1.4
2024Q4	17	15	16.8%	5.01	32.30	32.5%	27.1%	1.9	1.9
2024Q3	19	15	20.5%	4.54	34.18	29.1%	23.3%	-0.3	-0.3
2024Q2	20	15	24.4%	3.77	34.03	31.5%	24.6%	2.2	2.2
2024Q1	20	15	20.9%	4.18	34.33	31.7%	25.4%	0.7	0.7
2023Q4	18	15	16.5%	5.62	32.73	28.3%	23.9%	1.6	1.6
2023Q3	19	15	19.6%	4.87	34.23	26.2%	21.6%	1.1	1.1
2023Q2	19	15	19.4%	4.90	33.41	23.8%	19.5%	0.8	0.8
2023Q1	19	15	18.7%	5.42	33.55	21.6%	17.8%	0.3	0.3
2022Q4	18	15	14.3%	7.39	33.94	22.2%	18.8%	1.7	1.7
2022Q3	19	16	15.6%	6.02	34.67	20.2%	16.5%	-0.1	-0.1
2022Q2	18	15	16.6%	5.81	34.20	21.3%	17.4%	1.3	1.3
2022Q1	19	15	17.0%	5.75	34.40	18.7%	15.1%	0.3	0.3
2021Q4	18	15	16.2%	6.06	34.07	16.8%	14.5%	2.3	2.3
2021Q3	21	17	20.9%	4.66	37.30	48.3%	40.2%	0.5	0.5
2021Q2	22	18	19.9%	4.93	38.95	45.9%	36.7%	-0.1	-0.1
2021Q1	24	19	20.9%	4.73	42.24	43.3%	34.1%	0.1	0.1
2020Q4	23	20	11.8%	8.84	44.37	34.1%	30.6%	1.5	1.5
2020Q3	16	14	11.1%	10.07	30.90	13.4%	11.6%	0.2	0.2
2020Q2	17	13	20.1%	5.13	29.36	11.6%	9.6%	0.8	0.8
2020Q1	17	13	21.8%	4.69	29.07	12.2%	10.1%	0.4	0.4
2019Q4	21	19	8.2%	14.48	41.82	10.7%	9.7%	1.0	1.0
2019Q3	21	18	16.0%	6.64	40.00	4.7%	4.1%	-0.1	-0.1
2019Q2	21	18	15.5%	6.94	39.25	3.3%	2.8%	1.2	1.1
2019Q1	20	18	13.0%	7.81	39.21	2.9%	2.6%	0.1	0.0
2018Q4	19	17	10.5%	9.11	37.98	1.4%	1.3%	0.7	0.7
2018Q3	19	17	9.7%	9.74	38.56	4.2%	3.8%	0.0	-0.0
2018Q2	20	17	13.8%	6.91	38.38	4.8%	4.0%	1.1	1.1
2018Q1	20	18	6.9%	13.88	39.86	4.4%	4.1%	-0.6	-0.6
2017Q4	20	19	8.3%	11.52	40.85	6.5%	5.9%	1.0	0.8
2017Q3	20	18	7.5%	12.89	40.36	10.7%	9.9%	-0.7	-0.7
2017Q2	23	18	19.1%	5.09	39.90	–	–	0.7	0.6
2017Q1	23	21	7.4%	13.24	46.08	–	–	-0.0	-0.0
2016Q4	22	20	8.7%	11.32	44.74	–	–	1.5	1.5
2016Q3	21	20	7.6%	12.92	42.58	–	–	–	–